Publishes original research articles, letters, case reports, reviews/mini-reviews and guest edited thematic issues on various topics related to Biochemistry. Articles may be focused largely, but not exclusively, on contributions from India
Aims and Scope
The section Biochemistry of the journal Current Indian Science publishes original research and review articles, letters and special issues of interest to the readers that showcase the novelty, enlighten the futuristic thoughts, raise provocative questions and hypotheses regarding an interesting and important biological question in the various dimensions of biochemistry, and serves as a platform for the discussion of new ideas in the same field. It invigorates transdisciplinarity and provides quantitative insights into fundamental problems at the molecular, cellular, and systems and whole-organism levels.
This section is not limited to a specific aspect of the field but is instead devoted to a wide range of sub-fields in the area. Articles of interdisciplinary nature are particularly welcome. Submissions in the following areas are of special interest to the readers of this journal:
Chemical, physical, and computational methods in neuroscience
Enzyme inhibition and inhibitory processes
Epigenetics, chromatin structure and function
Mathematical, Computational, Biophysical and Statistical Modelling
Molecular basis of disease
Nucleic acid biology
Pharmaceuticals and therapeutics
Rizwan H. Khan Interdisciplinary Biotechnology Unit Aligarh Muslim University Aligarh India
Professor, Rizwan Hasan Khan received Ph.D. in Biotechnology from Aligarh Muslim University, Aligarh, India during the period of 1992-1996. Currently, he is working in the area of protein structure, function, protein misfolding or aggregation and amyloid induction and inhibition at Aligarh Muslim University. His research is focusing on many aspects of protein misfolding and aggregation such as designing suitable molecules for inducing aggregation in proteins to understand the mechanism of protein aggregation, to find out the molecular mechanism of toxicity of protein aggregates using neuronal cell lines and animal models, to find and synthesize new suitable drug molecule for the treatment of debilitating protein aggregation diseases. He is an editorial member of several reputed journals including IJBM, Plos One, CPPS, JBB, Journal of Biophysics etc.He has guided 23 PhD theses and completed 12 research projects. He has published around 325 papers in the journals of international repute with H index of 60 and total citation around 12766. His two patents are under process.